Skip to main content
. 2013 Apr 12;31(22):2565–2571. doi: 10.1016/j.vaccine.2013.03.055

Table 1.

Oligonucleotide primer sequences used.

Name Primers (5′… 3′) Function
1 GFP ins+ GGGACCTCGAGTATGGTGAGCAAGGGCGAGGAGC GFP amplification adding XhoI sites
2 GFP ins neg CCACTCCTCGAGATTTTACTTGTACAGCTCGTCC GFP amplification adding XhoI sites
3 N all b neg ACTAATGAGAATCACAATAATAAAAAGCACAG N RT and PCR amplification
4 N 200+ GCAGCATGGATACTGGAGACG N sequencing
5 N 300 neg GGTCAGCGGCTGGTCCTGTTCC N sequencing
6 N 560+ GGTTCACGTGGTCGTAGGAG N sequencing
7 N 750+ CCAGGTTATAGAGTAGATCAAGTATTTGGC N sequencing
8 N 920+ CTGTGGTGCCTAGAGATGACC N primer for mRNA PCR
9 N all+ CCAAGGGAAAACTTGTGAGGAACAC N PCR amplification
10 N start xho+ GGAACACTATTATAATAACAATCCTCGAGCATGGCAAGCAGTAAGG N amplification adding sticky ends
11 N stop xho neg TGTAGCAAGTCCTTACTCGAGTCAAAGTTCATTTTCACCAAG N amplification adding sticky ends
12 QX 1210 neg ACATTCAAAATTCATGCTTAA Diagnostic RT-PCR for QX IBV
13 QX 860+ TGTTAATACTACTCTGGCG Diagnostic RT-PCR for QX IBV
14 QX S1 1050+ GGTTTAATTCCTTGTCAGTTTCTCTTACTTATGG S1 sequencing
15 QX S1 1380+ GCTGCTAATTTTAGTTATTTAGCAGATGGTGG S1 sequencing
16 QX S1 270 neg CCTGAAGAGGTGCTGTCATAGC S1 sequencing
17 QX S1 400+ GGCATGATTCCACGTGATCATATTCG S1 sequencing
18 QX S1 550 neg CAGTAGTTTTGTTGGAAGTAAAAACAAGATCACC S1 sequencing
19 QX S1 end neg CGAACCATCTGGTTCAATACAAAATCTGC S1 PCR amplification
20 QX S1 start+ CCAGTTGTGAATTTGAAGAAAGAACAAAAGACCGACTTAG S1 PCR amplification
21 RT QX S1 neg CATCTTTAACGAACCATCTGG S1 RT amplification
22 S1 1380+ GCTGCTAATTTTAGTTATTTAGCAGATGGTGG S1 primer for mRNA PCR
23 S1 start xho+ GGTAAATTATTGCTCGAGGATGTTGGTGAAGTCACTGTTTTTAGTG S1 amplification adding XhoI sites
24 S1 stop xho neg GTTACGTTTTGCTCGAGTTAACGCCTACGACGATGTGAGCTATTGG S1 amplification adding XhoI sites
25 SX 3+ TAATACTGGYAATTTTTCAGA S1 sequencing